Chemkart Invests ₹10 Lakh in Wholly Owned Subsidiary

Chemkart India Ltd has invested ₹10 Lakhs in its wholly owned subsidiary, Vinstar Biotech Private Limited, through a rights issue. The investment was made by subscribing to 1,00,000 equity shares at face value. This capital infusion is intended for Vinstar Biotech's capital expenditure and working capital requirements. Vinstar Biotech is an R&D-driven nutraceutical company specializing in proprietary bioactive technologies. The transaction is considered a related party transaction but is conducted at arm's length. Vinstar Biotech's financials as of March 31, 2026, show a turnover of ₹223.43 Lakhs, a loss after tax of ₹(24.72) Lakhs, and a net worth of ₹(34.69) Lakhs. Chemkart's shareholding in Vinstar Biotech remains at 100% post-investment.